Literature DB >> 23713092

Pearls and oy-sters: acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura.

Julio C Rojas1, Chirantan Banerjee, Fazeel Siddiqui, Bardia Nourbakhsh, Craig M Powell.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23713092      PMCID： PMC3716404          DOI： 10.1212/WNL.0b013e318294b423

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  9 in total

1.  Atypical thrombotic thrombocytopenic purpura in a middle-aged woman who presented with a recurrent stroke.

Authors:  Modupe Idowu; Preethi Reddy
Journal:  Am J Hematol       Date:  2012-05-28       Impact factor: 10.047

2.  Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure.

Authors:  Tomoko Ono; Jun Mimuro; Seiji Madoiwa; Kenji Soejima; Yuji Kashiwakura; Akira Ishiwata; Katsuhiro Takano; Tsukasa Ohmori; Yoichi Sakata
Journal:  Blood       Date:  2005-09-27       Impact factor: 22.113

3.  Stroke in a young patient treated by alteplase heralding an acquired thrombotic thrombocytopenic purpura.

Authors:  Amandine Sevy; Emilie Doche; Christian Squarcioni; Pascale Poullin; Jacques Serratrice; Francois Nicoli; Pierre-Jean Weiller
Journal:  J Clin Apher       Date:  2010-12-13       Impact factor: 2.821

4.  Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group.

Authors:  G A Rock; K H Shumak; N A Buskard; V S Blanchette; J G Kelton; R C Nair; R A Spasoff
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

5.  ADAMTS13--more than just TMA and TTP.

Authors:  Kerstin Amann
Journal:  Nephrol Dial Transplant       Date:  2011-04-29       Impact factor: 5.992

6.  Rituximab induces remission of cerebral ischemia caused by thrombotic thrombocytopenic purpura.

Authors:  Han-Mou Tsai; Keith Shulman
Journal:  Eur J Haematol       Date:  2003-03       Impact factor: 2.997

Review 7.  Atypical presentations of thrombotic thrombocytopenic purpura: a review.

Authors:  Ravi Sarode
Journal:  J Clin Apher       Date:  2009       Impact factor: 2.821

8.  Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident.

Authors:  Katharine A Downes; Roslyn Yomtovian; H M Tsai; Bernard Silver; Cynthia Rutherford; Ravindra Sarode
Journal:  J Clin Apher       Date:  2004       Impact factor: 2.821

9.  Atypical presentations of thrombotic thrombocytopenic purpura.

Authors:  Timothy E O'Brien; Edward D Crum
Journal:  Int J Hematol       Date:  2002-12       Impact factor: 2.490
  9 in total
  6 in total

Review 1.  Pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Blood       Date:  2017-08-02       Impact factor: 22.113

Review 2.  Neurological and Neurosurgical Emergencies in Patients with Hematological Disorders.

Authors:  Martha L Cruz; Shama Farooq; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

Review 3.  Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT.

Authors:  Z DeFilipp; R F Duarte; J A Snowden; N S Majhail; D M Greenfield; J L Miranda; M Arat; K S Baker; L J Burns; C N Duncan; M Gilleece; G A Hale; M Hamadani; B K Hamilton; W J Hogan; J W Hsu; Y Inamoto; R T Kamble; M T Lupo-Stanghellini; A K Malone; P McCarthy; M Mohty; M Norkin; P Paplham; M Ramanathan; J M Richart; N Salooja; H C Schouten; H Schoemans; A Seber; A Steinberg; B M Wirk; W A Wood; M Battiwalla; M E D Flowers; B N Savani; B E Shaw
Journal:  Bone Marrow Transplant       Date:  2016-08-22       Impact factor: 5.483

4.  What's new in the diagnosis and pathophysiology of thrombotic thrombocytopenic purpura.

Authors:  J Evan Sadler
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2015

5.  Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: nationally representative data from 2007 to 2012.

Authors:  Ruchika Goel; Karen E King; Clifford M Takemoto; Paul M Ness; Aaron A R Tobian
Journal:  Transfusion       Date:  2016-04-15       Impact factor: 3.157

6.  Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT.

Authors:  Zachariah DeFilipp; Rafael F Duarte; John A Snowden; Navneet S Majhail; Diana M Greenfield; José López Miranda; Mutlu Arat; K Scott Baker; Linda J Burns; Christine N Duncan; Maria Gilleece; Gregory A Hale; Mehdi Hamadani; Betty K Hamilton; William J Hogan; Jack W Hsu; Yoshihiro Inamoto; Rammurti T Kamble; Maria Teresa Lupo-Stanghellini; Adriana K Malone; Philip McCarthy; Mohamad Mohty; Maxim Norkin; Pamela Paplham; Muthalagu Ramanathan; John M Richart; Nina Salooja; Harry C Schouten; Helene Schoemans; Adriana Seber; Amir Steinberg; Baldeep M Wirk; William A Wood; Minoo Battiwalla; Mary E D Flowers; Bipin N Savani; Bronwen E Shaw
Journal:  Biol Blood Marrow Transplant       Date:  2016-05-14       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.